Drugmaker says company will not have a vaccine ready before the US election
Moderna Therapeutics’s chief executive told the Financial Times that the company would not have a vaccine ready before the US election, and Japan adjusts for a digital economy. Plus, the FT’s metals and mining correspondent, Henry Sanderson, explains how western investors’ interest in gold is driving up its price.
Moderna chief says its vaccine won’t be ready before US election
Japan’s digital leap forward — and about time too
The new gold rush: western investors offset soft eastern demand
See acast.com/privacy for privacy and opt-out information.
A transcript for this podcast is currently unavailable, view our accessibility guide.
Get alerts on FT News Briefing when a new story is published